+ Filter
Loading...
Custom Services order now ship next day

Anti-CSF3R Recombinant Antibody Products

Anti-CSF3R Recombinant Antibody Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs offers a comprehensive portfolio of cutting-edge anti-CSF3R recombinant antibodies, backed by validated supporting data and first-class technical support, compatible with a wide range of immunology applications. These high-performance antibodies are engineered to be highly accurate and specific, ensuring researchers have greater efficiency in gaining insights into CSF3R pathogenicity and developing therapeutics.

GCSFR: A Viable Therapeutic Target in Cancer

The granulocyte colony-stimulating factor receptor (GCSFR), also known as CSF3R or CD114, is an important regulator of granulopoiesis. Recent research suggests that it is overexpressed in a variety of cancer types, where it promotes tumor growth by affecting both myeloid and non-myeloid immune cells. Given its relevance in carcinogenesis, GCSFR is a promising therapeutic target for the development of novel anticancer medicines.

Alternative Names

Colony-stimulating factor 3 receptor; GCSFR; G-CSF-R; G-CSF Receptor; granulocyte colony-stimulating factor receptor; CD114; Cluster of Differentiation 114; SCN7.

Background

The protein encoded by this gene is the receptor for colony-stimulating factor 3, a cytokine that controls the production, differentiation, and function of granulocytes. The encoded protein, which is a member of the family of cytokine receptors, may also function in some cell surface adhesion or recognition processes. Alternatively, spliced transcript variants have been described. Mutations in this gene are a cause of Kostmann syndrome, also known as severe congenital neutropenia.

Anti-CSF3R Recombinant Antibody Products

Creative Biolabs provides a comprehensive range of recombinant antibodies specifically designed to precisely target CSF3R. These versatile antibodies, available in multiple formats, exhibit exceptional specificity and affinity, making them ideal for a wide array of experimental techniques. By leveraging our advanced antibody engineering and production capabilities, we offer researchers high-quality tools to delve deeper into the intricate role of CSF3R in various biological processes, facilitating groundbreaking discoveries in the fields of immunology, oncology, and beyond.

Table 1. Featured anti-CSF3R recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
MOB-0140CT Recombinant Mouse anti-Human CSF3R Monoclonal antibody (MNN886) Human Mouse FC
MOB-1808z Mouse Anti-CSF3R Recombinant Antibody (clone 28F2) Human Mouse IgG1 WB, ELISA, FC, IHC
MOR-0829 Hi-Affi™ Rabbit Anti-CSF3R Recombinant Antibody (clone DS829AB) Human Rabbit IgG WB, FC
HPAB-0081-YJ Mouse Anti-CSF3R Recombinant Antibody (clone LMM-741) Human Mouse IgG1, κ FC, IP, WB
NEUT-549CQ Rat Anti-Csf3r Recombinant Antibody (clone CBL638) Mouse Rat IgG2b Neut

Creative Quality Control

Creative Biolabs is a leading biotechnology company focused on producing novel and effective therapeutic treatments. Our team of experts leverages cutting-edge technology and advanced research techniques to deliver customized solutions for a wide range of applications. We are always committed to quality and ensuring that every product meets the highest quality and performance requirements.

Customer Reviews

Excellent
Ku***r
Mouse Anti-CSF3R Recombinant Antibody (clone LMM-741) (HPAB-0081-YJ)
The anti-CSF3R antibody from Creative Biolabs has proven to be a useful tool in my study. Its remarkable specificity and sensitivity enabled me to obtain exact and reproducible findings. The technical support team has been really helpful, offering professional direction throughout my tests.
15/Oct/2022
Excellent
Sz***r
Mouse Anti-CSF3R Recombinant Antibody (clone 28F2) (MOB-1808z)
We were initially skeptical about finding a reliable anti-CSF3R antibody, but Creative Biolabs exceeded our expectations. Their antibody dramatically enhanced the quality of our WB and IHC studies. The strong signal and minimal background noise have allowed us to draw more accurate conclusions from our data. We're impressed with the quality and consistency of this product.
10/Dec/2023
Excellent
Sa***s
Afuco™ Anti-Human CSF3R ADCC Recombinant Antibody, ADCC Enhanced (AFC-181CL)
Creative Biolabs' anti-CSF3R antibody has proven to be a reliable and effective tool for our research. The antibody functioned admirably in our studies, yielding distinct and specific bands. The customer support crew was attentive and helpful in answering our questions. We're satisfied with the overall experience and will consider using Creative Biolabs' products for future research projects
17/May/2024

Anti-CSF3R Recombinant Antibody Production

Creative Biolabs employs advanced genetic engineering techniques to produce customized antibodies that specifically target the CSF3R protein. This innovative approach enables the efficient synthesis of high-quality antibodies, ensuring a consistent and reliable supply to meet diverse research and development needs.

Featured Anti-CSF3R Recombinant Antibody Production Platforms Fig.1 Milligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-CSF3R recombinant antibody production.

Fig.2 Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-CSF3R recombinant antibody production.

Anti-CSF3R Recombinant Antibody Modalities

Creative Biolabs provides a comprehensive selection of recombinant antibodies targeting CSF3R, offering researchers a versatile toolbox for their specific experimental needs. These antibodies are available in a variety of forms, allowing versatility and adaptability for a wide range of applications.

Fig.3 CSF3R antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-CSF3R recombinant antibody production and modalities.

CSF3R-Targeted Drug Information

Public Drug Information Targeting CSF3R

Table 2. Public drug targeting CSF3R.

Company Research Phase Classification Condition
Adello Biologics (Originator)
Amneal Pharmaceuticals
Kashiv Biosciences
Launched - 2022 Follow-on Products
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Neutropenia
Hanmi (Originator)
Spectrum Pharmaceuticals
Launched - 2022 Fc Fusion Proteins
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Cancer, breast
Cytopenia, chemotherapy- or radiotherapy-induced
Neutropenia
Accord Healthcare (Originator) Launched - 2015 Biosimilars
Follow-on Products
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Neutropenia
Fuji Pharma (Originator)
Kidswell Bio (Originator)
Mochida
Launched - 2013 Colony-Stimulating Factors (CSF)
Follow-on Products
Polypeptides, from 41 AA
Recombinant proteins
Neutropenia
Hospira (Pfizer)
Pfizer (Originator)
Launched - 2010 Biosimilars
Follow-on Products
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Acute radiation syndrome
Bone marrow and stem cell transplantation
Neutropenia
Neutropenia, febrile
Hexal (Originator)
Sandoz (Originator)
Sawai
Launched - 2009 Biosimilars
Follow-on Products
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Bone marrow and stem cell transplantation
Neutropenia
Transplantation, bone marrow
BioGeneriX
CT Arzneimittel (Originator)
Nippon Kayaku
ratiopharm (Originator)
Teva (Originator)
Launched - 2008 Biosimilars
Follow-on Products
Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Bone marrow and stem cell transplantation
Cytopenia, chemotherapy- or radiotherapy-induced
Neutropenia
Dr Reddy's Laboratories (Originator)
Dr. Reddy's Laboratories (Dr Reddy's Laboratories)
Launched - 2001 Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Agranulocytosis
Neutropenia
Kyowa Hakko Kirin (Kyowa Kirin)
Kyowa Hakko (Kyowa Kirin)
Kyowa Kirin (Originator)
Yakult Honsha
Launched - 1994 Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Agranulocytosis
Almirall
Chugai (Chugai Pharmaceutical)
Chugai Pharmaceutical (Originator)
Sanofi
Launched - 1991 Granulocyte Colony-Stimulating Factor (G-CSF)
Polypeptides, from 41 AA
Recombinant proteins
Acute myeloid leukemia
Anemia
Neutropenia

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

As a leader in antibody research, Creative Biolabs is dedicated to developing innovative antibody solutions for cancer therapy. Our anti-CSF3R recombinant antibodies, engineered for optimal performance, offer researchers powerful tools to investigate CSF3R's role in cancer progression. Contact us today to find out more about our goods and how they may help you with your study.

  • 0
  • 0
Cart
    Go to compare

    Go to compare